Artificial Intelligence: A New Frontier in Treating Epilepsy, Stroke, and Alzheimer’s Disease

The integration of Artificial Intelligence (AI) into neurology presents transformative opportunities for improving the diagnosis and treatment of Epilepsy, Stroke, and Alzheimer's disease. I reviewed recent studies and clinical trials that utilized AI technologies, such as machine learning algorithms and deep learning models, in the context of epilepsy, stroke, and Alzheimer's disease. The focus was on applications in diagnostic imaging, predictive modelling, and treatment optimization. AI has shown significant promise in each of the neurological conditions studied. In epilepsy, AI algorithms have demonstrated high accuracy in detecting seizures from EEG data and predicting seizure onset. For stroke, AI-driven imaging techniques have enhanced the precision of ischemic and haemorrhagic stroke detection, leading to faster and more accurate identification of candidates for thrombolysis and thrombectomy. In Alzheimer's disease, AI has improved early diagnosis through the analysis of neuroimaging and genetic data, tracking disease progression and identifying potential biomarkers. The findings highlight AI's potential to revolutionize neurology by offering more accurate and efficient diagnostic tools, predictive capabilities, and personalized treatment strategies. In epilepsy, AI can reduce the burden of manual EEG analysis, improve seizure management. In stroke, rapid AI-assisted diagnosis and intervention planning can significantly impact patient outcomes. In Alzheimer's disease, early detection and monitoring facilitated by AI can enhance accelerate the development of targeted therapies.AI applications in epilepsy, stroke, and Alzheimer's disease represent a significant advancement in neurological research and clinical practice.